Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 2Colonic Neoplasms 2Rectal Neoplasms 1Radiation Injuries 1Precancerous Conditions 1Neoplasms, Second Primary 1Neoplasms 1Head and Neck Neoplasms 1Head and Neck Fibrosis 1Erectile Dysfunction 1Colorectal Neoplasms 1Adenomatous Polyps 1

Interventions

Sildenafil Citrate 2udenafil 1methyl 3-mercaptopropionimidate 1bicalutamide 1alpha-Tocopherol 1Vitamin E 1Tamoxifen 1Tadalafil 1Tacrolimus 1Restraint, Physical 1Psychiatric Rehabilitation 1Preservation, Biological 1Pentoxifylline 1Menogaril 1Long-Term Synaptic Depression 1Intraoperative Neurophysiological Monitoring 1GPI 1485 1Exercise 1Erythropoietin 1Early Intervention, Educational 1Dutasteride 1Cell- and Tissue-Based Therapy 1Atorvastatin 1Arginine 1ArginMax 1Anastrozole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Erectile Dysfunction × alpha-Tocopherol × Clear all
NCT03830164 2023-10-17

Pentoxifylline, Atorvastatin, and Vitamin E in Treating Patients With Erectile Dysfunction After Radiation Therapy for Prostate Cancer

M.D. Anderson Cancer Center

Phase 2 Completed
14 enrolled 9 charts

Erectile Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡